Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008

NCT01903733 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
281
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer